skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 77  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 next page
Refined by: Database: SpringerOpen remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein
Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein
Material Type:
Article 		Add to My Research

Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein

Genome medicine, 2020-07, Vol.12 (1), p.68-15, Article 68 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1756-994X ;EISSN: 1756-994X ;DOI: 10.1186/s13073-020-00763-0 ;PMID: 32723359

Full text available

Citations Cited by
2
The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19
The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19
Material Type:
Article 		Add to My Research

The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19

The Protein Journal, 2020-06, Vol.39 (3), p.198-216 [Peer Reviewed Journal]

The Author(s) 2020 ;COPYRIGHT 2020 Springer ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1572-3887 ;EISSN: 1573-4943 ;EISSN: 1875-8355 ;DOI: 10.1007/s10930-020-09901-4 ;PMID: 32447571

Full text available

Citations Cited by
3
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Material Type:
Article 		Add to My Research

Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant

BMC medicine, 2022-03, Vol.20 (1), p.102-102, Article 102 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/s12916-022-02312-5 ;PMID: 35236358

Full text available

Citations Cited by
4
Characterization of accessory genes in coronavirus genomes
Characterization of accessory genes in coronavirus genomes
Material Type:
Article 		Add to My Research

Characterization of accessory genes in coronavirus genomes

Virology journal, 2020-08, Vol.17 (1), p.131-131, Article 131 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;The Author(s) 2020 ;ISSN: 1743-422X ;EISSN: 1743-422X ;DOI: 10.1186/s12985-020-01402-1 ;PMID: 32854725

Full text available

Citations Cited by
5
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Material Type:
Article 		Add to My Research

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection

Journal of biomedical science, 2022-01, Vol.29 (1), p.1-1, Article 1 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1423-0127 ;ISSN: 1021-7770 ;EISSN: 1423-0127 ;DOI: 10.1186/s12929-021-00784-w ;PMID: 34983527

Full text available

Citations Cited by
6
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
Material Type:
Article 		Add to My Research

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines

Journal of translational medicine, 2020-06, Vol.18 (1), p.222-3, Article 222 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1479-5876 ;EISSN: 1479-5876 ;DOI: 10.1186/s12967-020-02392-y ;PMID: 32493510

Full text available

Citations Cited by
7
Pango lineage designation and assignment using SARS-CoV-2 spike gene nucleotide sequences
Pango lineage designation and assignment using SARS-CoV-2 spike gene nucleotide sequences
Material Type:
Article 		Add to My Research

Pango lineage designation and assignment using SARS-CoV-2 spike gene nucleotide sequences

BMC genomics, 2022-02, Vol.23 (1), p.121-121, Article 121 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2164 ;EISSN: 1471-2164 ;DOI: 10.1186/s12864-022-08358-2 ;PMID: 35148677

Full text available

Citations Cited by
8
Mutations in SARS-CoV-2 structural proteins: a global analysis
Mutations in SARS-CoV-2 structural proteins: a global analysis
Material Type:
Article 		Add to My Research

Mutations in SARS-CoV-2 structural proteins: a global analysis

Virology journal, 2022-12, Vol.19 (1), p.220-19 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1743-422X ;EISSN: 1743-422X ;DOI: 10.1186/s12985-022-01951-7 ;PMID: 36528612

Full text available

Citations Cited by
9
D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity
D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity
Material Type:
Article 		Add to My Research

D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity

Applied microbiology and biotechnology, 2021-12, Vol.105 (24), p.9035-9045 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;COPYRIGHT 2021 Springer ;The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0175-7598 ;EISSN: 1432-0614 ;DOI: 10.1007/s00253-021-11676-2 ;PMID: 34755213

Full text available

Citations Cited by
10
Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review
Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review
Material Type:
Article 		Add to My Research

Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review

Journal of translational medicine, 2020-09, Vol.18 (1), p.358-11, Article 358 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1479-5876 ;EISSN: 1479-5876 ;DOI: 10.1186/s12967-020-02534-2 ;PMID: 32957995

Full text available

Citations Cited by
11
Convergent evolution of SARS-CoV-2 in human and animals
Convergent evolution of SARS-CoV-2 in human and animals
Material Type:
Article 		Add to My Research

Convergent evolution of SARS-CoV-2 in human and animals

Protein & cell, 2021-11, Vol.12 (11), p.832-835 [Peer Reviewed Journal]

Copyright reserved, 2021, The Author(s) ;The Author(s) 2021 ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1674-800X ;EISSN: 1674-8018 ;DOI: 10.1007/s13238-021-00847-6 ;PMID: 33929695

Full text available

Citations Cited by
12
SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome
SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome
Material Type:
Article 		Add to My Research

SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome

Stem cell reviews, 2021-02, Vol.17 (1), p.266-277 [Peer Reviewed Journal]

The Author(s) 2020 ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2629-3269 ;ISSN: 1550-8943 ;EISSN: 2629-3277 ;EISSN: 1558-6804 ;DOI: 10.1007/s12015-020-10010-z

Full text available

Citations Cited by
13
Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins
Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins
Material Type:
Article 		Add to My Research

Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins

The EMBO journal, 2024-04, Vol.43 (8), p.1484-1498 [Peer Reviewed Journal]

The Author(s) 2024 ;2024. The Author(s). ;ISSN: 0261-4189 ;EISSN: 1460-2075 ;DOI: 10.1038/s44318-024-00062-z ;PMID: 38467833

Full text available

Citations Cited by
14
Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants
Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants
Material Type:
Article 		Add to My Research

Structural and functional insights into the spike protein mutations of emerging SARS-CoV-2 variants

Cellular and molecular life sciences : CMLS, 2021-12, Vol.78 (24), p.7967-7989 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 ;2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG. ;The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021. ;ISSN: 1420-682X ;EISSN: 1420-9071 ;DOI: 10.1007/s00018-021-04008-0 ;PMID: 34731254

Full text available

Citations Cited by
15
Evolution of infectious bronchitis virus in the field after homologous vaccination introduction
Evolution of infectious bronchitis virus in the field after homologous vaccination introduction
Material Type:
Article 		Add to My Research

Evolution of infectious bronchitis virus in the field after homologous vaccination introduction

Veterinary research (Paris), 2019-11, Vol.50 (1), p.92-92, Article 92 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2019 ;ISSN: 1297-9716 ;ISSN: 0928-4249 ;EISSN: 1297-9716 ;DOI: 10.1186/s13567-019-0713-4 ;PMID: 31706335

Full text available

Citations Cited by
16
Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases
Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases
Material Type:
Article 		Add to My Research

Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases

Infection, 2020-10, Vol.48 (5), p.665-669 [Peer Reviewed Journal]

The Author(s) 2020 ;ISSN: 0300-8126 ;EISSN: 1439-0973 ;DOI: 10.1007/s15010-020-01486-5 ;PMID: 32737833

Full text available

Citations Cited by
17
A SARS-CoV-2 mutant from B.1.258 lineage with ∆H69/∆V70 deletion in the Spike protein circulating in Central Europe in the fall 2020
A SARS-CoV-2 mutant from B.1.258 lineage with ∆H69/∆V70 deletion in the Spike protein circulating in Central Europe in the fall 2020
Material Type:
Article 		Add to My Research

A SARS-CoV-2 mutant from B.1.258 lineage with ∆H69/∆V70 deletion in the Spike protein circulating in Central Europe in the fall 2020

Virus genes, 2021-12, Vol.57 (6), p.556-560 [Peer Reviewed Journal]

The Author(s) 2021 ;2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0920-8569 ;EISSN: 1572-994X ;DOI: 10.1007/s11262-021-01866-5 ;PMID: 34448987

Full text available

Citations Cited by
18
Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity
Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity
Material Type:
Article 		Add to My Research

Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity

Medical microbiology and immunology, 2023-02, Vol.212 (1), p.103-122 [Peer Reviewed Journal]

The Author(s) 2022 ;2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0300-8584 ;EISSN: 1432-1831 ;DOI: 10.1007/s00430-022-00760-7 ;PMID: 36583790

Full text available

Citations Cited by
19
COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein
COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein
Material Type:
Article 		Add to My Research

COVID-19 and iron dysregulation: distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein

Biology direct, 2020-10, Vol.15 (1), p.19-19, Article 19 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1745-6150 ;EISSN: 1745-6150 ;DOI: 10.1186/s13062-020-00275-2 ;PMID: 33066821

Full text available

Citations Cited by
20
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Material Type:
Article 		Add to My Research

Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein

Virology journal, 2021-01, Vol.18 (1), p.16-10, Article 16 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1743-422X ;EISSN: 1743-422X ;DOI: 10.1186/s12985-021-01490-7 ;PMID: 33435994

Full text available

Citations Cited by

Results 1 - 20 of 77  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2014  (2)
  2. 2014 To 2015  (6)
  3. 2016 To 2017  (7)
  4. 2018 To 2020  (16)
  5. After 2020  (47)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait